While targeting GPX4 holds promise in cancer treatment, a challenge arises from its widespread expression in both cancer and immune cells, which can potentially cause side effects when using traditional GPX4 inhibitors
At 20 mg/mL, 2.5 mg equals 12.5 units
FDA prescribing label pancreatic safety warning PubMed/PMC clinical gastrointestinal side-effect background source U.S
GLP-1-based therapies offer a pharmacological intervention that targets these mechanisms directly, allowing for more effective management of obesity
Providing your body with nutrients like vitamins A, C, D, and zinc can give it a solid foundation of immune support
A New Approach to Weight Management in Children As childhood obesity continues to climb, doctors are exploring new ways to support weight management in teens and adolescents